Furthermore, the company was awarded the first prize at the Shanghai Science and Technology Progress Awards for its project titled "Establishment of Intestinal Flora Disease Classification Mode and Clinical Application of Flora Transplantation Treatment". Leveraging this technology, the company offers integrated solutions for intestinal health that help balance gut environments while preventing disease occurrence and progression. Realbio Biotechnology creates a better life with advanced technology and safeguards human health!

Cutting-edge Product Innovation

Realbio's flagship product, COLOWELL, employs a pioneering technology that combines SFRP2 and SDC2 biomarker detection, yielding an impressive sensitivity and specificity level of approximately 92%.

Robust Research and Development

The company possesses a robust research and development capacity, with a diverse portfolio of ongoing projects, and has secured an extensive intellectual property portfolio, including over 140 patents and software copyrights.

Strong Commercial Presence

Realbio has established strong commercial partnerships with over 500 healthcare institutions, contributing to a substantial revenue of nearly one billion yuan in 2022.